Skip to the page

Data / Form D filings / Ventricle Health, Inc.

Ventricle Health, Inc.: Form D filing

Ventricle Health, Inc., a health care company in Greensboro, United States, filed a Form D with the SEC in 2023. The latest, on November 13, 2023, reports $8 million sold of a $8 million offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1150 REVOLUTION DRIVE, STUDIO 6, Greensboro, United States, 27405
Phone
(202) 380-8764
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2000394

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 13, 2023New notice$8,000,000$7,999,995$516Sep 26, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anurag KondapalliDirector
Carie CotterDirector
Sean O'DonnellExecutive Officer, Director
Matthew SouleDirector
Daniel BensimhonDirector

Every Form D from the week of Nov 13, 2023 · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Ventricle Health, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.